Cover Image
市場調查報告書

生物感應器的全球市場分析·預測 2020年:電化學生物感應器·壓電生物感應器·光生物感應器

Biosensors Market by Application (POC, Home Diagnostics, Research Labs, Biodefense, Environmental Monitoring), Product (Wearable, Non-Wearable), Technology (Electrochemical, Piezoelectric, Optical) & Geography - Global Analysis & Forecast to 2020

出版商 MarketsandMarkets 商品編碼 324151
出版日期 內容資訊 英文 193 Pages
訂單完成後即時交付
價格
Back to Top
生物感應器的全球市場分析·預測 2020年:電化學生物感應器·壓電生物感應器·光生物感應器 Biosensors Market by Application (POC, Home Diagnostics, Research Labs, Biodefense, Environmental Monitoring), Product (Wearable, Non-Wearable), Technology (Electrochemical, Piezoelectric, Optical) & Geography - Global Analysis & Forecast to 2020
出版日期: 2015年01月14日 內容資訊: 英文 193 Pages
簡介

全球生物感應器市場規模在2013年為113億9,000萬美金,預測在2014年到2020年間將以10.00%的年複合成長率成長,到2020將達到226億8,000萬美元的規模。

本報告提供全球生物感應器市場相關調查分析,提供您產品,技術,用途,及各地區的市場分析與預測,競爭情形及主要企業簡介等資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 各種臨床·非臨床用途的生物感應器引進促進生物感應器市場
  • 照護現場(POC)佔整體生物感應器市場大半
  • 亞太地區維繫生物感應器市場成長的主要原因:傳統醫療制度的升級及人口眾多
  • 技術進步及醫療費的上升預計將促進美國的生物感應器市場
  • 北美預計將持續處於生物感應器用途的市場上優勢
  • 生物感應器市場:已開發國家vs.新興國家
  • 穿戴式生物感應器影響全球醫療產業的可能性

第5章 市場概要

  • 簡介
  • 生物感應器技術的演進
  • 市場區隔
    • 各用途
    • 各技術
    • 各產品
    • 各地區
  • 市場動態
    • 推進因素
      • 奈米技術/奈米生物感應器的登場
      • 這幾年大幅的技術進步
      • 糖尿病患者的血糖值監測
      • 家用POC設備需求的增加
    • 阻礙因素
      • 商業化的延遲
      • 研究·開發相關成本高
      • 引進新治療行為的猶豫
    • 市場機會
      • 新興各國上的新機會
      • 食品產業,環境監測,及生化防禦等非醫療用途上生物感應器的利用
    • 課題
      • 政府法規:長的認證&認證循環
      • 照護現場(POC)市場上的價格壓力
    • 緊急的課題
      • 設備的高成本抑制生物感應器市場成長

第6章 產業趨勢

  • 簡介
  • 價值鏈分析
    • 價值鏈分析:生物感應器
  • 產業趨勢
  • 新興趨勢
    • 開放原始碼·連接型醫療平台
    • 個人化醫療:醫療模式
    • 實驗室·芯片集成
  • 生物感應器平台及經營模式
  • 波特的五力分析
  • PEST分析
    • 政治要素
    • 經濟要素
    • 社會要素
    • 技術性要素
  • 策略性基準
    • 技術整合 & 產品強化
    • 腫瘤/癌症檢驗市場的進入

第7章 生物感應器市場分析:各用途

  • 簡介
  • 照護站(POC)
    • 照護站(POC)用途:各地區
    • 照護站(POC)用途:各產品
    • 血糖值監測
    • 心肌標記
    • 傳染病檢查套件
    • 凝固監測套件
    • 妊娠及妊娠檢測套組
    • 血氣·電解質檢驗
    • 腫瘤/癌症標記
    • 尿液檢查實驗套件
    • 膽固醇實驗
    • 其他
  • 家庭診斷
    • 家庭診斷用途:各地區
    • 家庭診斷用途:各產品
  • 調查實驗室
  • 生物國防
  • 環境監測
    • 食品產業

第8章 生物感應器市場分析:各技術

  • 簡介
    • 生物感應技術比較分析
  • 電化學生物感應器
    • 電化學生物感應器的優點
    • 主要企業
    • 導電生物感應器
    • 電流檢測生物感應器
    • 電位計生物感應器
    • 其他
  • 壓電生物感應器
  • 光生物傳感器
  • 熱生物感應器
  • 其他

第9章 生物感應器市場分析:各產品

  • 簡介
  • 穿戴式生物感應器
    • 清單軟體
    • 眼鏡產品
    • 鞋子
    • 頸環
    • 身體衣著
    • 其他
  • 非穿戴式生物感應器

第10章 生物感應器市場分析:各地區

  • 簡介
  • 北美
  • 歐洲
  • APAC(亞太地區)
  • 其他地區(ROW)

第11章 競爭情形

  • 概要
  • 市場佔有率分析:生物感應器市場
  • 競爭情形·趨勢

第12章 企業簡介(概要·產品及服務·財務·策略&發展)

  • Abbott point of care, inc.
  • Acon laboratories, Inc.
  • Bayer ag
  • F. hoffman la-roche ltd.
  • LifeScan Inc.
  • LifeSensors Inc.
  • Medtronic inc.
  • Nova biomedical corporation
  • Pharmaco-kinesis corporation
  • Siemens AG
  • Universal Biosensors

第13章 附錄

圖表一覽

目錄
Product Code: SE 3097

The biosensor is a device which is used for detecting, recording, and transmitting information related to any physiological changes or the presence of various chemicals or biological materials in the environment. In other words, we can say that it is an analytical device, which converts the biological response into electrical signals. The biosensors technology is now being used for the development of various biosensor applications, such as the medical, healthcare, biodefense, environment monitoring, and food industries.

This report is based on an extensive research study of the biosensors market and aims at identifying the entire market and all its sub-segments through the extensively detailed classifications. The demand for the biosensors is expecting a significant growth and importance among the industry players across various verticals. APAC is projected to be the fastest growing markets due to the high adoption of medical diagnostics and testing devices.

This report is focused on giving a bird's eye-view of the industry with regard to the biosensors market, with qualitative analysis at each and every aspect of the classification done on the basis of products, technologies, applications, and geographies. The report provides a forecast of the growth of the biosensors market from 2014 to 2020. A complete competitive landscape of the current market is analyzed from the market share analysis and rankings of current key players; all the other details of the key players are discussed in their company profiles. The competitive information provided in this report includes market shares of the leading companies in the biosensors ecosystem, key developments, core strategies deployed by various players, mergers and acquisitions, new product developments, collaborations, and joint ventures of key manufacturers along with their company profiles.

The report also discusses the future of the global market with road-maps, upcoming technologies, markets, and applications with respect to the biosensors market. The key players in this industry include F. Hoffmann-La Roche Ltd. (Switzerland), LifeScan Inc. (U.S.), Bayer Healthcare AG (Germany), Abbott Point-of-Care Inc. (U.S.), Medtronic (U.S.), Siemens Healthcare (Germany), and others.

Table of Contents

1 introduction

  • 1.1 objectives of the study
  • 1.2 market definition
  • 1.3 study scope
    • 1.3.1 markets covered
    • 1.3.2 geographic scope
    • 1.3.3 Years considered for the study
  • 1.4 currency
  • 1.5 package size
  • 1.6 limitations
  • 1.7 stakeholders

2 research methodology

  • 2.1 research data
    • 2.1.1 secondary data
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 primary data
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
      • 2.1.2.3 Breakdown of primaries
  • 2.2 factor analysis
    • 2.2.1 introduction
    • 2.2.2 demand side analysis
      • 2.2.2.1 Growth in the Healthcare Expenditure
      • 2.2.2.2 Progression Toward Healthcare Decentralization
      • 2.2.2.3 Prevalence of Diabetes Continues to Increase
      • 2.2.2.4 Rapid Growth of the Aging Population
      • 2.2.2.5 Related Market Analysis: Transducers Market
      • 2.2.2.6 Poor Customer Perception
  • 2.3 Market size estimation
    • 2.3.1 Bottom-up approach
    • 2.3.2 top-down approach
  • 2.4 MARKET breakdown & DATA TRIANGULATION
  • 2.5 research assumptions and limitations
    • 2.5.1 assumptions
    • 2.5.2 limitations

3 Executive Summary

4 Premium insights

  • 4.1 adoption of biosensors in various CLINICAL and non-CLINICAL applications is driving THE biosensors Market
  • 4.1 point-of-care dominated the overall biosensors market, 2013
  • 4.2 key factors behind the growth of the biosensors market in APAC- upgrade of the existing healthcare systems & large population
  • 4.3 technological advancements & increased healthcare cost likely to drive the biosensors market in the U.S.
  • 4.4 north america expected to continue to dominate the market for biosensor applications
  • 4.5 Biosensors market: Developed vs. developing nations
  • 4.6 wearable biosensors likely to impact the global healthcare industry

5 Market Overview 4

  • 5.1 Introduction
  • 5.2 Evolution of the biosensors technology
  • 5.3 Market segmentation
    • 5.3.1 biosensors market, by application
    • 5.3.2 Biosensors market, by technology
    • 5.3.3 biosensors market segmentation: by product
    • 5.3.4 BIOSENSORS market segmentation: by geography
  • 5.4 Market dynamics
    • 5.4.1 Drivers
      • 5.4.1.1 Emergence of Nanotechnology/Nanobiosensors
      • 5.4.1.2 Significant technological advancements over the last few years
      • 5.4.1.3 Glucose monitoring in diabetics patients
      • 5.4.1.4 Increase in the demand for home based POC devices
    • 5.4.2 Restraints
      • 5.4.2.1 Slow rate of commercialization
      • 5.4.2.2 High cost involved in the research and development
      • 5.4.2.3 Reluctance toward the adoption of new treatment practices
    • 5.4.3 opportunities
      • 5.4.3.1 Emerging market in the developing countries
      • 5.4.3.2 Use of biosensors for non-medical applications, such as- the food industry, environmental monitoring, and biodefense
    • 5.4.4 Challenges
      • 5.4.4.1 Government regulations-long certification & approval cycles
      • 5.4.4.2 Pricing pressure in the point-of-care market
    • 5.4.5 burning issue
      • 5.4.5.1 High cost devices limit the growth of the biosensors market

6 industry trends 5

  • 6.1 introduction
  • 6.2 VALUE CHAIN ANALYSIS
    • 6.2.1 Value chain analysis: Biosensors
  • 6.3 industry trends
  • 6.4 emerging trends
    • 6.4.1 open, connected healthcare platforms
    • 6.4.2 personalized medicine -A medical model
    • 6.4.3 lAB ON A CHIP
  • 6.5 biosensors platform and business model
  • 6.6 PORTER'S FIVE FORCES ANALYSIS
    • 6.6.1 threats of new entrants
    • 6.6.2 threats of substitutes
    • 6.6.3 bargaining power of suppliers
    • 6.6.4 bargaining power of buyers
    • 6.6.5 Intensity of rivalry
  • 6.7 pEST ANALYSIS
    • 6.7.1 political factors
    • 6.7.2 economic factors
    • 6.7.3 social factors
    • 6.7.4 technological factors
  • 6.8 strategic benchmarking
    • 6.8.1 TECHNOLOGY INTEGRATION & PRODUCT ENHANCEMENT
    • 6.8.2 ENTRY INTO TUMOR/CANCER TESTING MARKET

7 biosensors market analysis, by application 7

  • 7.1 introduction
  • 7.2 point-of-care
    • 7.2.1 Point-of-Care Application, by Geography
    • 7.2.2 Point-of-Care Application, by Product
    • 7.2.3 glucose monitoring
    • 7.2.4 cardiac markers
    • 7.2.5 infectious diseases testing kits
    • 7.2.6 coagulation monitoring kits
    • 7.2.7 pregnancy and fertility testing kits
    • 7.2.8 blood gas and electrolyte
    • 7.2.9 tumor/cancer markers
    • 7.2.10 urinalysis testing kits
    • 7.2.11 cholesterol test
    • 7.2.12 others
  • 7.3 home diagnostics
    • 7.3.1 Home Diagnostics Application, by Geography
    • 7.3.2 Home Diagnostics Application, by Product
  • 7.4 research labs
    • 7.4.1 Research Lab Application, by Geography
    • 7.4.2 Research Lab Application, by Product
  • 7.5 biodefense
    • 7.5.1 Biodefense Application, by Geography
    • 7.5.2 Biodefense Application, by Product
  • 7.6 environmental monitoring
    • 7.6.1 Environmental Monitoring Application, by Geography
    • 7.6.2 Environmental Monitoring, by Product
    • 7.7 food industry

8 Biosensors Market analysis, By Technology 1

  • 8.1 Introduction
    • 8.1.1 Comparative Analysis of biosensing Technologies (biotransducers)
  • 8.2 Electrochemical Biosensors
    • 8.2.1 Advantages of Electrochemical Biosensors
    • 8.2.2 Major Companies
    • 8.2.3 Conductometric biosensors
    • 8.2.4 Amperometric biosensors
    • 8.2.5 potentiometric biosensors
    • 8.2.6 others
  • 8.3 Piezoelectric Biosensors
  • 8.4 Optical biosensors
  • 8.5 thermal biosensors
  • 8.6 Others

9 Biosensors market analysis, by product 1

  • 9.1 introduction
  • 9.2 wearable biosensors
    • 9.2.1 wrist-wear
    • 9.2.2 eye-wear
    • 9.2.3 foot-wear
    • 9.2.4 neck-wear
    • 9.2.5 body-wear
    • 9.2.6 others
  • 9.3 non-wearable biosensors

10 biosensors market analysis, by geography

  • 10.1 INTRODUCTION
  • 10.2 North AMERICA
  • 10.3 Europe
  • 10.4 APAC
  • 10.5 ROW

11 competitive landscape

  • 11.1 Overview
  • 11.2 market share analysis, biosensors market
  • 11.3 competitive situation and trends
    • 11.3.1 new product launches, 2011-2014
    • 11.3.2 Acquisition
    • 11.3.3 partnerships and agreements
    • 11.3.4 Expansions
    • 11.3.5 awards and recognition

12 company profiles (Overview, Products and Services, Financials, Strategy & Development)*

  • 12.1 abbott point of care, inc.
  • 12.2 acon laboratories, Inc.
  • 12.3 bayer ag
  • 12.4 f. hoffman la-roche ltd.
  • 12.5 LifeScan, Inc.
  • 12.6 LifeSensors Inc.
  • 12.7 medtronic inc.
  • 12.8 nova biomedical corporation
  • 12.9 pharmaco-kinesis corporation
  • 12.10 Siemens AG
  • 12.11 Universal Biosensors

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case Unlisted Companies.

13 Appendix

  • 13.1 insights of industry experts
  • 13.2 discussion guide
  • 13.3 introducing RT: real-time market INTELLIGENce
  • 13.4 available customizations
  • 13.5 Related Reports

LIST OF TABLES

  • TABLE 1 Increase in the demand for glucose monitoring systems, contributing to the growth of the biosensors market
  • TABLE 2 the slow rate of commercialization is hampering the growth of the biosensors market
  • TABLE 3 use of biosensors for non-medical applications is a prominent opportunity for the biosensors market
  • TABLE 4 Stringent government regulations and pricing pressures are the major challenges faced by the biosensors market
  • TABLE 5 Global Biosensor Market Size, by Application, 2013-2020 ($Billion)
  • TABLE 6 Biosensors Market Size, by Point-of-Care Application, 2013-2020 ($Billion)
  • TABLE 7 POC Applications IN THE BIOSENSORS MARKET, By Region, 2013-2020 ($million)
  • TABLE 8 poc Applications in the north american BIOSENSORS market, By Country, 2013-2020 ($million)
  • TABLE 9 poc Applications in the EUROPEAN BIOSENSORS market, By Country, 2013-2020 ($Million)
  • TABLE 10 poc Applications in the APAC BIOSENSORS market, By Country, 2013-2020 ($Million)
  • TABLE 11 poc Applications in the BIOSENSORS market, by Product, 2013-2020 ($million)
  • TABLE 12 poc Applications in the BIOSENSORS market, by Product, 2013-2020 ($Million)
  • TABLE 13 Glucose Monitoring kits IN THE BIOSENSORS MARKET, By Region, 2013-2020 ($million)
  • TABLE 14 Cardiac Markers IN THE BIOSENSORS MARKET, By Region, 2013-2020 ($Million)
  • TABLE 15 Infectious Diseases testing kits IN THE BIOSENSORS MARKET, By Region, 2013-2020 ($million)
  • TABLE 16 Coagulation Monitoring IN THE BIOSENSORS MARKET, By Region, 2013-2020 ($million)
  • TABLE 17 Pregnancy & Fertility Testing kits IN THE BIOSENSORS MARKET, By Region, 2013-2020 ($million)
  • TABLE 18 Blood Gas & Electrolytes IN THE BIOSENSORS MARKET, By Region, 2013-2020 ($million)
  • TABLE 19 Tumor or Cancer Markers in the BIOSENSORS MARKET, By Region, 2013-2020 ($million)
  • TABLE 20 Urinalysis Testing IN THE BIOSENSORS MARKET, By Region, 2013-2020 ($Billion)
  • TABLE 21 CHOLESTEROL Testing IN THE BIOSENSORS MARKET, By Region, 2013-2020 ($million)
  • TABLE 22 other applications IN THE BIOSENSORS MARKET, By Region, 2013-2020 ($million)
  • TABLE 23 Home Diagnostics IN THE BIOSENSORS MARKET, By Region, 2013-2020 ($million)
  • TABLE 24 home diagnostics IN THE NORTH AMERICAN BIOSENSORS MARKET, By Country, 2013-2020 ($million)
  • TABLE 25 home diagnostics IN THE EUROPEAN BIOSENSORS MARKET, By Country, 2013-2020 ($Million)
  • TABLE 26 home diagnostics IN THE APAC BIOSENSORS MARKET, By Country, 2013-2020 ($million)
  • TABLE 27 home diagnostics IN THE BIOSENSORS MARKET, by Product, 2013-2020 ($Million)
  • TABLE 28 home diagnostics IN THE WEARABLE BIOSENSORS MARKET, by product, 2013-2020 ($million)
  • TABLE 29 Research Labs IN THE BIOSENSORS MARKET, By Region, 2013-2020 ($million)
  • TABLE 30 Research Labs IN THE NORTH AMERICAN BIOSENSORS MARKET, By Country, 2013-2020 ($million)
  • TABLE 31 Research Labs IN THE European Biosensors Market, By Country, 2013-2020 ($million)
  • TABLE 32 Research Labs IN THE APAC Biosensors Market, By Country, 2013-2020 ($million)
  • TABLE 33 Research lab IN THE Biosensors Market, by Product, 2013-2020 ($million)
  • TABLE 34 research lab IN THE wearable Biosensors Market, by Product, 2013-2020 ($million)
  • TABLE 35 Biodefense IN THE Biosensors Market, By Region, 2013-2020 ($million)
  • TABLE 36 Biodefense IN THE north american Biosensors Market, By Country, 2013-2020 ($million)
  • TABLE 37 Biodefense IN THE European Biosensors Market, By Country, 2013-2020 ($million)
  • TABLE 38 Biodefense IN THE APAC Biosensors Market, By Country, 2013-2020 ($million)
  • TABLE 39 biodefense applications IN THE Biosensors Market, by Product, 2013-2020 ($Million)
  • TABLE 40 biodefense applications IN THE wearable biosensors market, By product, 2013-2020 ($million)
  • TABLE 41 Environmental Monitoring IN THE biosensors market, By Region, 2013-2020 ($million)
  • TABLE 42 Environmental Monitoring IN THE North American Biosensors Market, By Country, 2013-2020 ($million)
  • TABLE 43 Environmental Monitoring IN THE European Biosensors Market, By Country, 2013-2020 ($million)
  • TABLE 44 Environmental Monitoring IN THE APAC Biosensors Market, By Country, 2013-2020 ($million)
  • TABLE 45 environmental monitoring applications IN THE Biosensors Market, by Product, 2013-2020 ($million)
  • TABLE 46 environmental monitoring applications IN THE WEARABLE Biosensors Market, by product, 2013-2020 ($million)
  • TABLE 47 enzyme biosensor for detecting food components
  • TABLE 48 Food Industry IN THE Biosensors Market, By Region, 2013-2020 ($million)
  • TABLE 49 Food Industry IN THE NORTH AMERICAN Biosensors Market, By Country, 2013-2020 ($million)
  • TABLE 50 Food Industry IN THE European Biosensors Market, By Country, 2013-2020 ($Billion)
  • TABLE 51 Food Industry IN THE APAC BIOSENSORS MARKET, By Country, 2013-2020 ($million)
  • TABLE 52 Comparative Analysis biotransducers used in biosensors
  • TABLE 53 Global biosensors Market, by technology, 2013-2020 ($Billion)
  • TABLE 54 Commercial self-monitoring blood glucose systems based on electrochemical biosensors
  • TABLE 55 Optical biosensors Market, by technology, 2013-2020 ($Billion)
  • TABLE 56 Global biosensors Market, by Product, 2013-2020 ($Billion)
  • TABLE 57 Wearable biosensors Market, by product, 2013-2020 ($Billion)
  • TABLE 58 Wearable biosensors Market, by Application, 2013-2020 ($Billion)
  • TABLE 59 wrist-wear Wearable biosensors Market, by Application, 2013-2020 ($Billion)
  • TABLE 60 Non-Wearable biosensors Market, by Application, 2013-2020 ($Billion)
  • TABLE 61 Biosensors Market, By Region, 2013-2020 ($Billion)
  • TABLE 62 north America: Biosensors Market, By Country, 2013-2020 ($million)
  • TABLE 63 north America: Biosensor Market, by Application, 2013-2020 ($million)
  • TABLE 64 Europe: Biosensors Market, By Country, 2013-2020 ($million)
  • TABLE 65 Europe: Biosensor Market, by Application, 2013-2020 ($million)
  • TABLE 66 APAC: Biosensors Market, By Country, 2013-2020 ($million)
  • TABLE 67 APAC: Biosensor Market, by Application, 2013-2020 ($million)
  • TABLE 68 ROW: Biosensor Market, by Application, 2013-2020 ($million)
  • TABLE 69 new product launches, 2011-2014
  • TABLE 70 acquisitions, 2012-2014
  • TABLE 71 Partnerships and agreements, 2011-2014
  • TABLE 72 expansions, 2011-2014
  • TABLE 73 awards and recognitions, 2011-2014

LIST OF FIGURES

  • FIGURE 1 markets covered
  • FIGURE 2 RESEARCH design
  • FIGURE 3 healthcare expenditure across various prominent countries in the biosensors market, 2011
  • FIGURE 4 decentralization across various prominent countries in the biosensors market, 2011
  • FIGURE 5 prevalence of type 1 diabetes, by Age group, 2013
  • FIGURE 6 Increase in the aging population, by country (2005 vs. 2010)
  • FIGURE 7 Global Transducers market analysis and estimation : geographic split (2013 vs 2015)
  • FIGURE 8 bottom-up approach
  • FIGURE 9 top-down approach
  • FIGURE 10 market breakdown & data triangulation
  • FIGURE 11 assumptions of the research study
  • FIGURE 12 limitations of the research study
  • FIGURE 13 roadmap for biosensors
  • FIGURE 14 POC holds the prominent share among all the biosensors applications
  • FIGURE 15 North America holds the lions share in the global biosensors market
  • FIGURE 16 rising demand for POC diagnostics DEVICES likely to contribute to the GROWTH OF biosensors market
  • FIGURE 17 Point of care: largest market for biosensors, driven by the glucose monitoring application
  • FIGURE 18 Japan CAPTUREd THE maximum SHARE IN THE biosensors market in APAC, 2013
  • FIGURE 19 U.S. commanded the maximum share of the biosensors market , 2013
  • FIGURE 20 north america expected to witness the highest usage of biosensor technology, (2013)
  • FIGURE 21 Developing markets to grow faster than the developed ones
  • FIGURE 22 wearable biosensors: key growth driver for the point- of- care market
  • FIGURE 23 Road map for the biosensors technology
  • FIGURE 24 biosensors MARKET segmentation: BY application
  • FIGURE 25 biosensors MARKET segmentation: BY technology
  • FIGURE 26 biosensors market segmentation: by product
  • FIGURE 27 biosensors MARKET segmentation: BY geography
  • FIGURE 28 the growing demand for glucose monitoring in diabetic patients will propel the demand for biosensors
  • FIGURE 29 The biomedical applications of the nanobiosensors
  • FIGURE 30 VALUE CHAIN ANALYSIS (2013): MAJOR VALUE IS ADDED DURING the R&D and testing PHASEs
  • FIGURE 31 MINIATURIZATION IS THE LEADING TREND IN THE CURRENT BIOSENSORS MARKET
  • FIGURE 32 biosensor platform and business model
  • FIGURE 33 porter's five forces analysis
  • FIGURE 34 STRATEGIC BENCHMARKING: ROCHE AND BD DIAGNOSTICS LARGELY ADOPTED the INORGANIC GROWTH STRATEGIES FOR TECHNOLOGY INTEGRATION AND PRODUCT ENHANCEMENT
  • FIGURE 35 STRATEGIC BENCHMARKING: ROCHE leads the TUMOR/CANCER TESTING MARKET
  • FIGURE 36 point-of-care diagnostics
  • FIGURE 37 POC application to witness the highest growth IN APAC
  • FIGURE 38 Wearable biosensors to register a prominent growth in the POC application
  • FIGURE 39 north america holds a prominent share in the glucose monitoring biosensors market
  • FIGURE 40 europe to be one of the important markets for the coagulation monitoring biosensors
  • FIGURE 41 North america holds the largest share for the cancer markers
  • FIGURE 42 increase in the obesity diseases will drive the demand for the cholesterol testing kits
  • FIGURE 43 north america holds the largest share for the home diagnostic application
  • FIGURE 44 wearable biosensors hold a great demand in the home diagnostics applicationS
  • FIGURE 45 research lab applications to witness a prominent growth in apac
  • FIGURE 46 wearable biosensors hold the major share in the research lab applications
  • FIGURE 47 biodefense application to register a significant growth in APAC
  • FIGURE 48 Wearable biosensors are expected to witness a prominent growth in the biodefense application
  • FIGURE 49 environment monitoring application to witness a prominent growth in ROW
  • FIGURE 50 wearable biosensors dominate the environmental monitoring application segment
  • FIGURE 51 apac to witness a prominent growth for the biosensors market in the food industry
  • FIGURE 52 Types of electrochemical biosensors
  • FIGURE 53 wearable biosensors hold the major share in the biosensors market
  • FIGURE 54 APAC to grow at highest cagr for global biosensors market
  • FIGURE 55 APAC- an attractive destination for all biosensor applications
  • FIGURE 56 north america market snapshot
  • FIGURE 57 Europe: Biosensors Market, By country, 2013-2020 ($ Million)
  • FIGURE 58 APAC Market snapshot
  • FIGURE 59 china to witness prominent growth in apac
  • FIGURE 60 companies adopted new product launches as the key growth strategy over the last three years
  • FIGURE 61 abbott: GREW AT THE highest cagr BETWEEN 2009 and 2013
  • FIGURE 62 global Biosensors Market share, by key player, 2013
  • FIGURE 63 MARKET EVOLUTION FRAMEWORK
  • FIGURE 64 competition for market share: Acquisition was the key strategy
  • FIGURE 65 geographic revenue mix
  • FIGURE 66 abbott laboratories, inc.: COMPANY SNAPSHOT
  • FIGURE 67 abott point-of-care, inc.: swot analysis
  • FIGURE 68 bayer ag: COMPANY SNAPSHOT
  • FIGURE 69 f. hoffman la-roche ltd.: COMPANY SNAPSHOT
  • FIGURE 70 F. Hoffmann-La Roche Ltd.: SWOT
  • FIGURE 71 johnson & johnson: cOMPANY SNAPSHOT
  • FIGURE 72 medtronic, inc.: COMPANY SNAPSHOT
  • FIGURE 73 medtronic, inc.: swot
  • FIGURE 74 Siemens AG: COMPANY SNAPSHOT
  • FIGURE 75 siemens ag: swot
  • FIGURE 76 UNIVERSAL BIOSENSORS: COMPANY SNAPSHOT
  • FIGURE 77 universal biosensors: swot
Back to Top